Etomidate
Back to searchMolecule Structure
Scientific Name
Etomidate
Description of the Drug
Etomidate is a short-acting intravenous anesthetic indicated for the induction of anesthesia and supplementation of subpotent anesthesia during short operative procedures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00292
http://www.drugbank.ca/drugs/DB00292
Brand Name(s)
Amidate, Etomidate
Company Owner(s)
Luitpold Pharmaceuticals Inc, Hikma Farmaceutica Portugal Sa, Mylan Laboratories Ltd, Par Sterile Products Llc, Caplin Steriles Ltd, Rising Pharma Holding Inc, Gland Pharma Ltd, Hospira Inc, Eugia Pharma Specialities Ltd, Emcure Pharmaceuticals Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL39487 | |
Human Metabolome Database | HMDB0014437 | |
DrugBank | DB00292 | |
PubChem: Thomson Pharma | 14749667 | |
PubChem | 667484 | |
Mcule | MCULE-1817647743 | |
LINCS | LSM-37126 | |
Nikkaji | J17.549H | |
PDBe | V8D | |
BindingDB | 50125935 | |
DrugCentral | 1109 | |
ChemicalBook | CB4113298 | |
Guide to Pharmacology | 5463 | |
rxnorm | ETOMIDATE | AMIDATE |
PubChem: Drugs of the Future | 12013395 | |
ChEBI | 4910 | |
ZINC | ZINC000000001408 |